A New Way to Take Charge of Severe Hypos
During a recent Breakthrough T1D Facebook Live event, Mary Beth McNerney of Xeris Pharmaceuticals and Christine Beebe, MS, RD and…
Nation’s Largest Insurer Expands Insulin Pump Coverage
In a victory for Breakthrough T1D’s Coverage2Control Campaign, people with T1D now have more choice in how they manage their…
A Message to Our Community
Breakthrough T1D is making the following commitments internally and to the T1D community to deliver tangible results for Black Americans…
Breakthrough T1D’s One Night: The Power of Us Is Unstoppable
One Night. One Community. One Purpose: to show the world the undeniable power of people living with T1D.
Tandem Control-IQ—Now Authorized For Children
Tandem Diabetes announced FDA clearance of an expanded pediatric indication for the Tandem t:slim X2™ insulin pump with Control-IQ™ technology…
At ADA, Breakthrough T1D-Funded Research Takes Center Stage (featuring a “Happy Hour” with Dr. Aaron Kowalski)
At the American Diabetes Association’s Scientific Sessions, which was held virtually from June 12-16, scientists presented on some of the…
The Importance of Dexcom CLARITY: From Telemedicine to Ultra Marathons
Elite T1D Athlete Eric Tozer and Dexcom Certified Diabetes Educator (CDE) Cher Pastore discuss Dexcom CLARITY technology.
Severe Hypoglycemia: Be Prepared, not Afraid
Fear of Hypoglycemia is a real thing. Learn how you and your loved ones with T1D can overcome it.
ADA’s Scientific Sessions: Day 4
The American Diabetes Association’s Scientific Sessions is here! Until June 16, scientists will present some of the most updated topics,…
FreeStyle Libre 2 Authorized for Use in the U.S.
On June 15, 2020, Abbott announced that the FDA has authorized the FreeStyle Libre 2 System. The Libre 2 gained…
